Article

Validating Exercise in T2DM

Author(s):

Your patients can't hear this from you enough – exercise improves diabetes control.

Exercise significantly improves metabolic parameters in type 2 diabetes mellitus (T2DM) patients, irrespective of improvement in cardiorespiratory fitness. Read about this and two additional studies that show the benefits of exercise in diabetes management.

Study 1: Metabolic Parameters Improve Even in Fitness Non-responders  

• Patients with T2DM who exercise can trim waist size and body fat, and control blood glucose, even if they do not see cardiorespiratory benefits.

• About 30% of exercisers are unable to improve their cardiorespiratory fitness levels despite diligent exercise (non-responders).

• These researchers evaluated the impact of exercise on metabolic parameters among 202 patients with T2DM who were non-responders to fitness training. The participants were part of the Health Benefits of Aerobic and Resistance Training in Individuals With Type 2 Diabetes trial.

• Waist circumference, percentage of body fat, and hemoglobin A1c levels all improved in diabetic patients who exercised compared to those who did not.

• Beneficial effects of exercise were seen in those who did aerobics, resistance training, or a combination of the 2 compared to a control group that did not exercise.

• The researchers suggest that exercise-training programs for people with T2DM should measure improvements in glycemic control, waist circumference, and percentage of body fat.

Study 2: Intensive Lifestyle Interventions Play a Prime Role in Diabetes Management

• Intensive lifestyle intervention in obese patients with T2DM should play a prime role in diabetes management, according to the results of a new retrospective observational study.

• These researchers evaluated diabetes remissions after 1 year of a 12-week intensive program for diabetes weight management in a real-world clinical practice.

• Among 120 obese patients with T2DM who completed the program, 88 patients returned for follow-up at 1 year.

• About one-quarter of patients (21.6%) had major improvement in their glycemic control.

• Four patients (4.5%) achieved either partial or complete diabetes remission on no anti-hyperglycemic medications for 1 year; 2 achieved partial remission (2.3%) and 2 achieved complete remission (2.3%).

• Patients who achieved diabetes remission had shorter diabetes duration (less than 5 years) and lower A1C (less than 8%) and were treated with fewer than 2 oral medications. They achieved a weight reduction of more than 7% after 12 weeks.

• The results indicate that a subset of obese patients with T2DM is appropriate for intensive lifestyle intervention with the aim of inducing diabetes remission.

Study 3: Aerobic Exercise Interferes with Pain of Diabetic Peripheral Neuropathy

• Painful diabetic peripheral neuropathy is a common complication of diabetes.

• These researchers examined the effect of aerobic exercise on pain and interference of pain in the daily lives of people with diabetic peripheral neuropathy.

• The pilot study included 20 patients who participated in 3 supervised aerobic exercises each week for 16 weeks.

• Patients experienced significantly less pain interference in walking, normal work, relationship with others, and sleep.

• There were no significant changes in pain intensity.

• The changes in pain interference but not pain intensity suggest a psychological component to an exercise program.

Take-home Messages

• Exercise improves diabetes control regardless of improvement in exercise capacity.

• A subset of obese patients with T2DM who go through intensive lifestyle interventions can achieve diabetes remission and stop using anti-hyperglycemic medications.

• Perceived pain interference may be reduced following an aerobic exercise intervention among people with painful diabetic peripheral neuropathy, without a change in pain intensity.

Related Videos
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Rahul Aggarwal, MD | Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.